Rare Kidney Stone Consortium Patient Registry
Recruiting now
Conditions studied: Primary Hyperoxaluria, Dent Disease, Cystinuria, APRT Deficiency
In brief
The purpose of this study is to collect medical information from a large number of patients in many areas of the world with primary hyperoxaluria (PH), Dent disease, Cystinuria and APRT deficiency. This information will create a registry that will help us to compare similarities and differences in patients and their symptoms. The more patients we are able to enter into the registry, the more we will be able to understand the Primary Hyperoxalurias,Dent disease, cystinuria and APRT and learn better ways of caring for patients with these diseases.
Key facts
- Study ID
- NCT00588562
- Run by
- Mayo Clinic
- People needed
- 730
- Starts
- 2003-07-01
- Expected to finish
- 2028-06-01
- Last updated by the study team
- 2026-07-10
Who can join
Age: any, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Individuals must have a definitive diagnosis of Primary Hyperoxaluria, Dent Disease, Cystinuria or APRT Deficiency.
- Individuals have a family history of a sibling with Primary Hyperoxaluria,Dent Disease, Cystinuria or APRT Deficiency.
You may not qualify if…
- Individuals who do not have Primary Hyperoxaluria, Dent Disease, Cystinuria or APRT Deficiency.
Where it is running
- Dent Disease Registry -Mayo Clinic — Rochester, Minnesota, United States (enrolling)
- Primary Hyperoxaluria Registry - Mayo Clinic — Rochester, Minnesota, United States (enrolling)
- Cystinuria Registry - New York University — New York, New York, United States (enrolling)
- APRT Registry - Landspitali Universtiy Hospital — Reykjavik, Iceland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.